Aeglea Biotherapeutics shares owned by Remedium Capital Partners
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Remedium Capital Partners
from 13F filings
Historical chart of Remedium Capital Partners investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Remedium Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Remedium Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $74M | 1.5M | 50.44 |